Intermittent Subcutaneous Apomorphine Therapy for ‘Off’ Episodes in Parkinson’s DiseaseA 6-Month Open-Label Study

被引：0
|
作者：
Richard M. Trosch
Dee Silver
Peter B. Bottini
机构：
[1] The Parkinson’s Disease and Movement Disorders Center,
[2] Coastal Neurological Group,undefined
[3] Mylan Laboratories Inc.,undefined
来源：
CNS Drugs | 2008年 / 22卷
关键词：
Apomorphine; Evaluation Visit; Dopamine Receptor Agonist; Motor Complication; Subcutaneous Apomorphine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose: The outpatient follow-up phase of the apomorphine (APO) 303 study assessed the long-term efficacy and safety of intermittent subcutaneous apomorphine for ‘off’ episodes in patients with advanced Parkinson’s disease.
引用
收藏
页码：519 / 527
页数：8
相关论文
共 50 条
  • [41] Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: A 6-month, open-label, randomized trial
    Szefler, SJ
    Warner, J
    Staab, D
    Wahn, U
    Le Bourgeois, M
    van Essen-Zandvliet, EEM
    Arora, S
    Pedersen, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (01) : 45 - 50
  • [42] The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension
    Angelo Tremblay
    Jean-Philippe Chaput
    Sonia Bérubé-Parent
    Denis Prud’homme
    Claude Leblanc
    Natalie Alméras
    Jean-Pierre Després
    European Journal of Clinical Pharmacology, 2007, 63
  • [43] The effect of topiramate on energy balance in obese men:: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension
    Tremblay, Angelo
    Chaput, Jean-Philippe
    Berube-Parent, Sonia
    Prud'homme, Denis
    Leblanc, Claude
    Almeras, Natalie
    Despres, Jean-Pierre
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (02) : 123 - 134
  • [44] Apomorphine sublingual film versus subcutaneous apomorphine in the treatment of OFF episodes in Parkinson's disease: results from an assessment of patient satisfaction
    Schwarz, J.
    Carroll, C.
    Ebersbach, G.
    Kulisevsky, J.
    Tessitore, A.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    Thach, A.
    MOVEMENT DISORDERS, 2022, 37 : S352 - S352
  • [45] SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION
    Rovin, Brad
    Furie, Richard
    Houssiau, Frederic A.
    Contreras, Gabriel
    Teng, Y. K. O.
    Curtis, Paula
    Madan, Anuradha
    Jones-Leone, Angela
    Gonzalez-Rivera, Tania
    Okily, Mohamed
    Roth, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [46] PSILOCYBIN THERAPY FOR DEPRESSION AND ANXIETY IN PARKINSON'S DISEASE: AN OPEN-LABEL PILOT STUDY
    Bradley, Ellen
    Sakai, Kimberly
    Fernandes-Osterhold, Gisele
    Szigeti, Balazs
    Ludwig, Connie
    Ostrem, Jill
    Tanner, Caroline
    Bock, Meredith
    Llerena, Katiah
    Finley, Patrick
    O'Donovan, Aoife
    Zuzuarregui, Jose Rafael
    Busby, Zachary
    McKernan, Amber
    Penn, Andrew
    Wang, Aliss
    Rosen, Raymond
    Woolley, Joshua
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 407 - 408
  • [47] Lurasidone dosing in a 6-month open label long term extension study
    Liang, S.
    Pikalov, A.
    Zhao, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S324 - S324
  • [48] A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis
    Lovell, Daniel J.
    Dare, Jason A.
    Francis-Sedlak, Megan
    Ball, Julie
    LaMoreaux, Brian D.
    Von Scheven, Emily
    Reinhardt, Adam
    Jerath, Rita
    Alpan, Oral
    Gupta, Ramesh
    Goldsmith, Donald
    Zeft, Andrew
    Naddaf, Henry
    Gottlieb, Beth
    Jung, Lawrence
    Holt, Robert J.
    PEDIATRIC RHEUMATOLOGY, 2018, 16
  • [49] AN OPEN-LABEL, 6-MONTH OBSERVATIONAL STUDY OF PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS RECEIVING RISPERIDONE LONG ACTING INJECTION
    Hustig, Harry
    Newton, Richard
    Nyst, Phil
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2009, 43 : A56 - A56
  • [50] A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis
    Daniel J. Lovell
    Jason A. Dare
    Megan Francis-Sedlak
    Julie Ball
    Brian D. LaMoreaux
    Emily Von Scheven
    Adam Reinhardt
    Rita Jerath
    Oral Alpan
    Ramesh Gupta
    Donald Goldsmith
    Andrew Zeft
    Henry Naddaf
    Beth Gottlieb
    Lawrence Jung
    Robert J. Holt
    Pediatric Rheumatology, 16
12345